Analytical Science
What Mass Spectrometry Can and Cannot Prove About a Peptide
Mass agreement, fragment evidence, modification localization, and full molecular identity are different levels of support in peptide mass spectrometry.
Educational content only. Not medical advice.
Intact mass is a strong filter, not a complete identity
High-resolution instruments can estimate monoisotopic or average mass and isotope pattern with high precision. Agreement with a calculated formula excludes many alternatives, but it may not distinguish sequence isomers, leucine from isoleucine, epimers, positional modifications with the same composition, or connectivity variants. Adducts, charge-state assignment, calibration, and deconvolution also affect the reported value. The theoretical mass must include termini, counter chemistry, and intended modifications.
Fragment ions provide sequence-position evidence
Tandem mass spectrometry isolates a precursor and induces fragmentation. Series of backbone ions can support residue order and locate some modifications. Confidence depends on spectrum quality, fragmentation method, mass tolerance, coverage, competing assignments, and whether diagnostic ions are present. Missing fragments create unresolved regions. A database score is a statistical match under search settings, not direct observation of every bond.
Sample preparation and separation affect what is observed
Ionization efficiency varies with sequence, charge, hydrophobicity, modification, salts, and matrix. Minor impurities can ionize more strongly or weakly than the main peptide. Chromatographic separation reduces mixture complexity and supplies retention information, but co-elution remains possible. Digestion-based mapping introduces enzyme specificity, missed cleavages, and preparation artifacts. Negative evidence requires a stated detection capability, not simply absence from a spectrum.
Orthogonal confirmation closes mass-spectrometry blind spots
Reference standards, amino-acid analysis, terminal methods, chiral or stereochemical analysis, disulfide mapping, chromatography, spectroscopy, and functional assays may be needed depending on identity claims. Data files, software versions, databases, search parameters, false-discovery controls, and manual review should be documented. This page teaches evidence interpretation and does not certify a peptide based on a screenshot or vendor report.
Evidence limits
- Mass-spectrometry confidence depends on instrument, fragmentation, calibration, separation, software, and search space.
- Some stereoisomers, positional isomers, and connectivity variants require additional methods.
- A spectrum screenshot cannot authenticate an unverified material for personal use.
Sources and further reading
These sources ground the definitions and evidence boundaries on this page. A citation is a route for verification, not an endorsement of a product or personal use.
U.S. Food and Drug Administration
Sameness Evaluations in an ANDA: Active Ingredients
Official draft guidance describing evidence used to establish active-ingredient sameness, including physicochemical characterization and orthogonal analytical support.
Open sourceHUPO Proteomics Standards Initiative
ProForma 2.0: Unifying the Encoding of Proteoforms and Peptidoforms
Primary community standard for representing peptide sequences and localized modifications in proteomics data.
Open sourceCommon questions
Can mass spectrometry distinguish leucine from isoleucine?
Standard mass alone cannot because they are isobaric; specialized fragmentation or orthogonal evidence may help.
Does 100% sequence coverage prove purity?
No. It supports sequence observation but does not quantify every impurity or establish stereochemistry and physical state.
Why pair chromatography with mass spectrometry?
Separation reduces mixture complexity and adds retention behavior, improving detection and assignment of related species.
Continue with context
Continue in the evidence workspace
Explore the complete PeptideSchool research workspace to organize sources, compare evidence layers, and follow related peptide science. Premium tools remain educational and do not provide individualized medical guidance.